# Propanc Biopharma, Inc.: Form 8-K, filed Feb 3, 2017

- Company: [Propanc Biopharma, Inc.](/companies/ppcb.md) (CIK 1517681)
- Form: 8-K
- Filed: 2017-02-03
- Accepted by EDGAR: Feb 3, 2017, 16:34 ET
- Period: 2017-01-27
- Accession: 0001144204-17-005927
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1517681/000114420417005927/v458191_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1517681/000114420417005927/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1517681/000114420417005927/v458191_8k.htm

Filed Feb 3, 2017.
Source: SEC EDGAR, the filing index for accession 0001144204-17-005927. Last ingested by Listed: Nov 14, 2026, 18:42 ET. No prices; not investment advice.
